Transcript Slide 1
Technology & Methods Seminar “Blast and Other Methods of Probabilistic Sequence Comparison” Arcady Mushegian Bioinformatics Thursday, May 25, 1:00p.m. Classroom (1st floor, Administration Building) Schedule with abstracts and previous presentation slides can be found on: K:\Weekly Seminar Schedule\Thursday -- Technology & Methods Information regarding previous seminars can be found at: http://research.stowers-institute.org/wiw/external/Seminars/index.htm .. Laurence FLORENS [email protected] Proteomics Rooms 351-357 bm X ie L R on i g_ L Tr i a W in o or r km an D u G er K to n ru m J a la sp uf er se n B a au yr m a C nn of fm C o n an aw ay A Number of samples Over 2000 Samples Analyzed since Oct 2003 300 250 200 2003 150 2004 2005 100 2006 50 0 High-Throughput Proteomics: MudPIT Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Complex Protein Mixtures Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Complex Protein Mixtures Types of samples we deal with: Whole cell lysates Membrane/Organelle preps Co-IPed proteins Affinity purified proteins Any biochemically-sound protein mixture and appropriate negative controls Quantities: low µg to 500µg What we need to know about your samples: Details of prep: Organism Amino acid sequence(s) Buffer Concentration, Silver-stained gel, Western Blot Protein content or PTMs Drop off: -80°C Freezer (Hallway Room 351) Complex Protein Mixtures - Troubleshooting Sample form: Small starting volume (<50ul) can be digested directly Dried protein pellet after TCA-precipitation (PREFERRED) Problems with “Sticky Stuff”: Glycerol High Detergent (e.g. 2% SDS) DNA/RNA Solutions: Keep as low as possible or dialyze out Methanol/Chloroform extraction Benzonase w/o Benzonase w/ Benzonase RT: 0.00 - 20.05 RT: 0.00 - 116.97 NL: 3.86E9 100 Base Peak MS 95 ScMcd1Myc_Meta_ 90 Ti_401 3.45 100 95 3.96 2.85 90 RT: 0.00 - 20.02 100 95 90 13.19 100 74.50 83.00 10.99 89.42 84.82 13.84 95 95.75 90.38 97.63 103.33 107.94 112.42 14.10 90 10.40 85 4.02 85 RT: 0.00 - 117.08 NL: 1.11E9 Base Peak MS ScMcd1Myc_Meta_ Ti_101 NL: 4.29E9 Base Peak MS ScMcd1Myc_Meta_ Ti_102 80 80 75 80 75 70 39.52 65 4.29 4.35 71.42 70 70 70.43 65 65 69.51 68.86 60 Relative Abundance Relative Abundance 60 55 0.79 50 45 1.00 1.80 2.01 40 1.09 18.30 35 45 30 40 25 2.57 2.82 2.96 20 9.76 15 9.13 6.94 7.23 6.23 6.30 7.82 3.79 5 10 8.41 8.73 9.01 0 1 25 2 3 4 5 6 7 8 9 11.63 11 12.62 12 14.61 15.16 15.96 16.51 13 14 15 16 17 89.94 99.47 20.33 18.08 0 1 2 3 4 5 6 7 8 9 14.65 19 20 0 10 22.65 86.33 11.11 108.52 97.22 79.25 77.28 94.19 85 116.69 NL: 4.27E9 Base Peak MS ScMcd1Myc_Meta_ Ti_103 30 40 50 60 Time (min) 70 80 90 100 12 13 14 15 16 17 18 19 20 102.65 95 101.42 90 111.66 85 107.77 NL: 4.28E9 Base Peak MS ScMcd1Myc_Meta_ 114.87 Ti_104 85 80 71.43 66.68 55 50 82.96 45 60.85 15 15.76 45.16 18.93 23.97 29.18 70 80 90 100 110 44.50 10 20 30 40 50 60 Time (min) 70 80 90 100 50.85 5 23.82 26.07 58.53 67.93 10 20 30 40 50 60 Time (min) 75.03 78.81 82.01 70 80 88.52 91.16 90 NL: 4.28E9 114.70 Base Peak 112.65 MS ScMcd1Myc_Meta_ Ti_106 96.94 101.06 104.86 105.10 94.62 100 110 0 NL: 1.63E9 Base Peak MS ScMcd1Myc_Meta_ Ti_405 54.39 95 90 15.50 75 58.32 10 20 30 40 50 67.03 60 Time (min) 106.32 112.18 115.49 75.92 78.37 82.45 89.21 93.72 70 80 90 100 110 NL: 1.44E9 Base Peak MS ScMcd1Myc_Meta_ Ti_406 60.58 100 95 62.41 90 85 85 80 80 75 75 75 91.20 70 70 70 48.73 50.28 32.85 0 RT: 0.00 - 97.06 100 111.38 105.99 20.98 22.53 6.32 12.02 12.77 115.10 102.45 106.32 92.73 80 80 23.01 110 RT: 0.00 - 117.03 85 15 10 8.17 12.51 14.05 14.85 16.40 RT: 0.00 - 117.05 MS ScMcd1- 90 Myc_Meta_ Ti_105 85 5.57 11.08 90 62.56 46.78 34.71 100 NL: 3.87E9 95 Base Peak 95 61.33 20 31.56 5 0 0 0 RT: 0.00 - 117.03 0.31 100 5.27 3.82 45.69 25 10 53.72 54.12 51.93 0 60 Time (min) 30 35.58 40.04 28.54 50 35 35.97 15 67.59 53.56 52.57 10 5 40 60.85 40.47 40 62.38 59.29 51.09 0 30 45 20 73.59 70.17 72.24 45.62 20 20 60.68 55 74.89 25 60.70 10 90 50 43.18 25 52.33 0 46.42 30 30 20 NL: 3.23E9 Base Peak MS ScMcd1Myc_Meta_ Ti_404 54.25 95 60 55 50 35 76.39 81.26 35 63.28 61.75 52.75 52.58 110 65 45.12 40 40 35 44.36 100 39.72 100 84.46 45 40 43.35 37.69 38.38 34.21 90 70 Relative Abundance Relative Abundance 86.35 Relative Abundance 55 15.24 15.90 20.88 80 75 60 94.99 60 5 70 95.58 98.48 90.04 60 15 60 Time (min) 61.77 65 10 50 80 75 70 25 40 112.46 87.31 13.58 65 30 104.38 109.83 30 85 39.77 75 70 65.36 20 12.85 80 73.93 65 45 10 RT: 0.00 - 116.96 NL: 1.88E9 Base Peak MS ScMcd1Myc_Meta_ Ti_403 54.86 90 76.50 14.11 70 50 0 110 RT: 0.00 - 117.02 3.62 5.41 9.00 100 12.61 80 75 99.95 0 10 11 Time (min) 95 83.56 80.03 7.24 94.08 88.39 35.71 32.68 20 100 84.10 8.25 10.44 103.61 83.04 74.56 68.26 24.55 26.60 13.89 2.67 4.38 18.70 19.32 16.14 16.91 17.44 81.00 65.38 16.33 12.31 13.06 13.70 10.61 8.64 9.25 9.63 RT: 0.00 - 117.05 4.15 3.38 95 90 73.68 16.02 14.47 5 5.07 5.24 5.49 6.24 7.28 0 18 RT: 0.00 - 117.00 100 58.11 36.88 15.77 10 4.83 34.05 4.57 5 10 Time (min) 20 15 4.56 0 40.27 40.82 63.14 52.16 4.49 1.38 1.31 1.03 5 5.26 19.21 19.93 10.53 0 37.67 30 15.16 1.64 1.51 1.44 10 15.38 5.75 3.50 10 93.19 56.40 35 15 52.26 46.08 44.62 40 20 63.32 62.27 54.66 60.63 9.98 53.57 18.26 3.02 3.43 15 50 45 4.42 1.71 25 64.82 47.99 30 2.50 25 55 2.30 2.22 65.40 35 2.22 30 20 50 45 50 2.15 35 55 47.81 40 68.60 65.99 55 60 Relative Abundance Relative Abundance 60 Relative Abundance 62.84 75 2.71 70 72.09 65 58.27 70 65 65 65 Relative Abundance 50 12.79 60 55 90.43 15.70 50 45 45 40 90.27 40 35 65 60 Relative Abundance 12.50 Relative Abundance 55 61.15 60.86 60 12.25 60 Relative Abundance 89.81 85 80 75 NL: 3.07E9 Base Peak MS ScMcd1Myc_Meta_ Ti_402 62.49 85 4.22 55 50 45 55 92.36 50 45 92.03 40 40 35 35 89.40 35 30 30 13.43 30 25 90.91 30 90.20 25 20 97.55 104.01 15 14.46 5 19.57 24.59 29.85 34.98 39.99 10 20 30 40 67.58 60 Time (min) 23.03 26.65 30.43 0 70 80 88.97 87.87 80.14 81.91 84.46 78.65 73.70 13.51 20 15 12.37 12.11 15 10 0 50 25 20 5 0 0 86.73 86.38 10 60.60 45.12 61.70 25 11.37 115.26 14.07 14.79 65.73 88.26 70.75 52.70 53.54 9.65 6.55 7.66 110.85 89.51 76.03 78.79 10 10.19 20 105.69 94.70 15 90 100 110 10 20 30 40.92 44.19 49.10 40 50 54.53 62.06 60 Time (min) 71.29 75.96 77.30 70 33.81 40.52 83.49 80 90 100 13 IDed Proteins 110 5 6.05 11.79 12.62 42.20 49.10 10 77.40 39.53 13.30 20.62 21.88 32.02 20 30 47.76 44.82 58.59 67.15 69.31 80.00 0 0 10 40 50 60 Time (min) 70 6.64 4.17 5 80 85.85 87.94 90 116.79 99.71 107.29 111.12 100 110 11.20 10.66 7.55 66.66 73.24 16.14 18.98 0 0 5 10 15 20 26.92 29.17 25 30 36.15 40.29 35 40 47.11 45 53.91 50 Time (min) 57.81 56.76 55 60 65 70 75 80 67 IDed Proteins 85 90 95 Generating Peptides Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Generating Peptides Proteomic Surveying: Endoproteinase Lys-C + Trypsin MKLSEVFEQE IDPVMQSLGY CCGRKLEFSP QTLCCYGKQL CTIPRDATYY SYQNRYHFCE KCFNEIQGES VSLGDDPSQP QTTINKEQFS KRKNDTLDPE LFVECTECGR KMHQICVLHH EIIWPAGFVC DGCLKKSART RKENKFSAKR LPSTRLGTFL DSMCRLELKL NSS Generating Peptides Proteomic Surveying: Endoproteinase Lys-C + Trypsin MKLSEVFEQE IDPVMQSLGY CCGRKLEFSP QTLCCYGKQL CTIPRDATYY SYQNRYHFCE KCFNEIQGES VSLGDDPSQP QTTINKEQFS KRKNDTLDPE LFVECTECGR KMHQICVLHH EIIWPAGFVC DGCLKKSART RKENKFSAKR LPSTRLGTFL DSMCRLELKL NSS PTMs: High Sequence Coverage MSQAIAEKQP SQEVKMEAKM EVDQPEPADT QPEDISESKV EDCKMESTET EERSTELKTE IKEEEDQPST SATQSSPAPG QSKKKIFKPE ELRQALMPTL EALYRQDPES LPFRQPVDPQ LLGIPDYFDI VKSPMDLSTI KRKLDTGQYQ EPWQYVDDIW LMFNNAWLYN RKTSRVYKYC Generating Peptides Proteomic Surveying: Endoproteinase Lys-C + Trypsin MKLSEVFEQE IDPVMQSLGY CCGRKLEFSP QTLCCYGKQL CTIPRDATYY SYQNRYHFCE KCFNEIQGES VSLGDDPSQP QTTINKEQFS KRKNDTLDPE LFVECTECGR KMHQICVLHH EIIWPAGFVC DGCLKKSART RKENKFSAKR LPSTRLGTFL DSMCRLELKL NSS PTMs: High Sequence Coverage MSQAIAEKQP SQEVKMEAKM EVDQPEPADT QPEDISESKV EDCKMESTET EERSTELKTE IKEEEDQPST SATQSSPAPG QSKKKIFKPE ELRQALMPTL EALYRQDPES LPFRQPVDPQ LLGIPDYFDI VKSPMDLSTI KRKLDTGQYQ EPWQYVDDIW LMFNNAWLYN RKTSRVYKYC Post-Translational Modifications: Triple/Multiple Digest • Sample is split into x aliquots • Digest using x different proteases • Analyze samples individually • Interpret spectra using SEQUEST MacCoss et al. (2002) Proc Natl Acad Sci U S A. 99:7900-7905 Trypsin Subtilisin Elastase MudPIT MudPIT MudPIT Generating Peptides: DmSNS SP Extracellular 86.6% 5 Ti + 2 Es + 1 PK (1479 AA, 162kDa) Maggie Chen, Kiran Kocherlakota, Jeff McDermott … Cytodomain Maggie Chen, Kiran Kocherlakota, Jeff McDermott Generating Peptides - Troubleshooting No tryptic peptides are obtained from particular protein Overdigestion with non-specific proteases No positively charged amino acids in peptides Multidimensional Chromatography Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Multidimensional Chromatography Small digest volumes (<200µl): 3-phase 100µm Fused Silica Large digest volumes (>200µl): split-3-phase 250µm Fused Silica 100µm FS 100µm FS RP - C18 250µm FS RP - C18 waste SCX Filtered Union with 2µm Frit 250µm FS 250µm FS RP - C18 SCX RP - C18 Peptides Peptides Multidimensional Chromatography • Cycle 1 – Reverse Phase Gradient • Cycle 2_Step 1 – Salt Pulse • Cycle 2_Step 2 – Reverse Phase Gradient H2O MeCN NH4OAc • Cycle 3_Step 1 – Increase Salt Pulse • Cycle 3_Step 2 – Reverse Phase Gradient HPLC 60 Buffer (%) 40 20 2.4kV 0 0 20 40 60 Time (min) 80 100 Number of Cycles depends on Sample Complexity Tandem Mass Spectrometry Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Tandem Mass Spectrometry Deca-XP vs LTQ (3D vs Linear Ion Trap) Hardware improvements for LTQ: Trapping efficiency (no rf field in ion injection axis), Ion capacity (linear configuration of mass analyzer -> larger volume), ~2x Detection efficiency (radial ejection of ions + 2 detectors) ~3x Ion ejection rate (while maintaining same resolution) Should significantly improve the number of detected peptides/proteins Blackler et al. (2006) Anal. Chem.78:1337-13344 160 140 120 100 80 Spectral Count 220 60 20 XP LTQ AK 00 04 11 /I TRnter s CRAP2 ex SP20 R 70 SBgr1 TR M R7 e T AP d8 TRRA 100 APP3 26 T S3 AR TRAur 0 C1RAP92 05 P85 /P 0 TR NuC2 A t2 MP LC ED37 M 6 TRSu R1 APrf5 HSAR 24a C0 TRPC292 TR FL 96 A AP J1 01 T CDP95 24 93RA K 0re /M P28 la ed 5 te d/ CTR 25 KI D F AAK P 111 M 025 E M D8 ED 7 -- Number of Proteins Tandem Mass Spectrometry Deca-XP vs LTQ 240 ~10µg FLAG-tagged Mediator Prep Total Mediator 300 180 ~2.5x more Protein IDs More Proteins that matter: not necessarily More spectra per protein (Quantitation, PTMs) XP LTQ 200 250 200 150 100 40 50 0 0 Tandem Mass Spectrometry XP Varying amounts of SpRunt1 (535AA, 59kDa) Constant HsMediator (~20µg Total) 800 LTQ Varying amounts of Pfs25 (185AA, 20kDa) Constant HsMediator (~10µg Total) XP LTQ Spectral Count 700 600 500 400 300 200 100 0 1E-4 1E-3 0.01 0.1 Spiked Protein (% of Total Protein Quantity, w/w) Both machines: Detection limit is ~0.05% of Total Protein Quantity (w/w) LTQ: more peptides/spectra detected for same quantities, i.e. greater confidence Tandem Mass Spectrometry The increase in number of spectra obtained from the LTQ results in: much larger files (x10) significantly increase in computational overhead (Storage and Search Time) Blackler et al. (2006) Anal. Chem.78:1337-13344 Computational Overhead Dan Thomasset Computational Overhead Dan Thomasset Instrumentation Priorities XP On-going Protein Identification Projects LTQ 1. Quantitation (isotopic labeling) 2. PTMs 3. Low Abundance Proteins 4. New Protein Identification Projects Matching MS/MS Spectra to Peptides Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Matching MS/MS Spectra to Peptides Search engine: SEQUEST® Protein Sequence Databases: Need to be as comprehensive as possible (whole genomes) Need to include “custom” sequences Updates Shuffled Sequences: Used to estimate False Discovery Rates (FDR) FDR 2 x( Shuffled_ SpectralCount) TotalSpectralCount Data Analysis Cells Tissues Embryos Proteins Lysis Purification Peptide Mixture Digestion Tandem Mass Spectrometry 2D Chromatography Protein List Data Analysis Database Matching MS/MS Spectrum Filtering & Assembling Data: DTASelect Through P: drive http://bioinfo/proteomics/ SQTs PARSE DTASelect ASSEMBLE FILTER High-stringency Filtering Criteria to limit FDR: Cross-correlation score (XCorr) DeltaCN Peptide Length Peptide Ends Tabb et al. (2002) J Proteome Res 1: 21-26 DTASelect.html (DTASelect-filter.txt) Comparing Protein Lists: CONTRAST n Protein Lists CONTRAST COMPARE MERGE Contrast.html (Contrast.txt) Text files MSAccess Tabb et al. (2002) J Proteome Res 1: 21-26 Comparing Protein Lists: contrast-report n Protein Lists contrast-report Mike Coleman COMPARE report.xls Dan He Comparing Protein Lists: contrast-report n Protein Lists contrast-report Mike Coleman COMPARE report.xls Dan He Relative Abundance: NSAF Quantitative Information from MudPIT dataset? Sequence Coverage: high for small proteins / low for large proteins Spectral Count: large proteins contribute more peptides/spectra Normalized Spectral Abundance Factor ( NSAF) k ( SpectralCount / Length) k N (SpectralCount / Length) i 1 i Values between 0 and 1 Best approximation of protein levels in a sample Allows comparisons across multiple runs and across different instruments Relative Abundance: NSAF Erika Geisbrecht Mingan Shi PTM Analysis Modification Delta Mass Residues Symbol Methylation 14 KST # Hydroxylation 16 KD @ Oxidation 16 M @ Dimethylation 28 RK ~ Acetylation 42 KST ^ Phosphorylation 80 STY * Ubiquitination 114 K % Glycosylation: N-linked: PNGFase, which leaves modified N (Dmass= +1 Da) O-linked: beta-eliminate O-glycosylations with NH4OH, which leaves modified S and T (Dmass= -1 Da) PTM Analysis Flowchart Mike Coleman ptm-report Mike Coleman contrast-ptm Time-line